Iteos Therapeutics Inc expected to post earnings of $4.95 a share - Earnings Preview

iTeos Therapeutics

08/11/2021 15:07

* Iteos Therapeutics Inc  ITOS.OQ   ITOS.O  is expected to show
a rise in quarterly revenue when it reports  results on November
10 (estimated). 
* The Cambridge, Massachusetts-based company is expected to
report revenue of $161.125 million, according to the mean
estimate from 4 analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Iteos Therapeutics Inc
is for earnings of $4.95 per share. For the same quarter last
year, the company reported a loss of 48 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $52​, about 43% above​ its last closing
price of $29.62. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.45       -0.41      -0.75     Missed  -81.2
 Mar. 31 2021  -0.48       -0.48      -0.39     Beat    18.4
 Dec. 31 2020              -0.42      -0.43     Missed  -1.8​
 Sep. 30 2020  -0.36       -0.36      -0.48     Missed  -31.9
 ​​Jun.        -0.47       -0.47      -29.49    Missed  -6,208
 30 2020                                                
                                                        ​
 This summary was machine generated November 8 at 15:07 GMT.  All
figures in US dollars unless otherwise stated